Drugplain

Moxifloxacin Hydrochloride Tablets, 400 mg 400 mg/1

Moxifloxacin Hydrochloride Tablets, 400 mg · TABLET, FILM COATED · REMEDYREPACK INC.

No Recall HistoryCurrently in Shortage
Plain English

Moxifloxacin Hydrochloride Tablets, 400 mg is a tablet, film coated containing moxifloxacin hydrochloride tablets, 400 mg at 400 mg/1, taken oral. Manufactured by REMEDYREPACK INC..

Key Facts

Brand Name
Moxifloxacin Hydrochloride Tablets, 400 mg
Generic Name
Moxifloxacin Hydrochloride Tablets, 400 mg
NDC Code (Product)
70518-4312
Manufacturer
REMEDYREPACK INC.
Strength
400 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
ANDA208682
Marketing Start
03/18/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective3 reports
condition aggravated1 reports
depersonalisation/derealisation disorder1 reports
disease progression1 reports
dizziness1 reports
electrocardiogram qt prolonged1 reports
empyema1 reports
epilepsy1 reports
pneumonia streptococcal1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE Moxifloxacin tablets are a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below: Community Acquired Pneumonia ( 1.1 ) Skin and Skin Structure Infections: Uncomplicated ( 1.2 ) and Complicated ( 1.3 ) Complicated Intra-Abdominal Infections ( 1.4 ) Plague ( 1.5 ) Acute Bacterial Sinusitis ( 1.6 ) Acute Bacterial Exacerbation of Chronic Bronchitis ( 1.7 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin hydrochloride and other antibacterial drugs. Moxifloxacin hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ( 1.8 ) 1.1 Community Acquired Pneumonia Moxifloxacin tablets are indicated in adult patients for the treatment of Community Acquired Pneumonia caused by susceptible isolates of Streptococcus pneumoniae (including multi-drug resistant Streptococcus pneumoniae [MDRSP]), Haemophilus influenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pne

Dosage & Administration

2 DOSAGE AND ADMINISTRATION Type of Infection Dose Every 24 hours Duration (days) Community Acquired Pneumonia ( 1.1 ) 400 mg 7 to 14 Uncomplicated Skin and Skin Structure Infections (SSSI) ( 1.2 ) 400 mg 7 Complicated SSSI ( 1.3 ) 400 mg 7 to 21 Complicated Intra-Abdominal Infections ( 1.4 ) 400 mg 5 to 14 Plague ( 1.5 ) 400 mg 10 to 14 Acute Bacterial Sinusitis ( 1.6 ) 400 mg 10 Acute Bacterial Exacerbation of Chronic Bronchitis ( 1.7 ) 400 mg 5 No dosage adjustment in patients with renal or hepatic impairment. ( 8.6 , 8.7 ) 2.1 Dosage in Adult Patients The dose of moxifloxacin tablets is 400 mg (orally) once every 24 hours. The duration of therapy depends on the type of infection as described in Table 1. Table 1: Dosage and Duration of Therapy in Adult Patients Type of Infection a Dose Every 24 hours Duration b (days) Community Acquired Pneumonia ( 1.1) 400 mg 7 to 14 Uncomplicated Skin and Skin Structure Infections (SSSI ) ( 1.2 ) 400 mg 7 Complicated SSSI ( 1.3 ) 400 mg 7 to 21 Complicated Intra-Abdominal Infections ( 1.4 ) 400 mg 5 to 14 Plague ( 1.5 ) c 400 mg 10 to 14 Acute Bacterial Sinusitis (ABS) ( 1.6 ) 400 mg 10 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB

Contraindications

4 CONTRAINDICATIONS Moxifloxacin hydrochloride is contraindicated in persons with a history of hypersensitivity to moxifloxacin or any member of the quinolone class of antibacterials [see Warnings and Precautions (5.8) ]. Known hypersensitivity to Moxifloxacin hydrochloride or other quinolones ( 4 , 5.8 )

Drug Interactions

7 DRUG INTERACTIONS Interacting Drug Interaction Multivalent cation-containing products including : antacids, sucralfate, multivitamins Decreased Moxifloxacin hydrochloride absorption. Take moxifloxacin tablet at least 4 hours before or 8 hours after these products. ( 2.2 , 7.1 , 12.3 ) Warfarin Anticoagulant effect enhanced. Monitor prothrombin time/INR, and bleeding. (6, 7.2 , 12.3 ) Class IA and Class III antiarrhythmics: Proarrhythmic effect may be enhanced. Avoid concomitant use. ( 5.6 , 7.5 ) Antidiabetic agents Carefully monitor blood glucose. ( 5.11 , 7.3 ) 7.1 Antacids, Sucralfate, Multivitamins and Other Products Containing Multivalent Cations Fluoroquinolones, including moxifloxacin hydrochloride, form chelates with alkaline earth and transition metal cations. Oral administration of moxifloxacin hydrochloride with antacids containing aluminum or magnesium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as didanosine buffered tablets for oral suspension or the pediatric powder for oral solution, may substantially interfere with the absorption of moxifloxac

Adverse Reactions

6 ADVERSE REACTIONS The following serious and otherwise important adverse reactions are discussed in greater detail in the warnings and precautions section of the label: • Disabling and Potentially Irreversible Serious Adverse Reactions Including Tendinitis and Tendon Rupture, Peripheral Neuropathy, and Central Nervous System Effects [see Warnings and Precautions (5.1) ] • Tendinitis and Tendon Rupture [see Warnings and Precautions (5.2) ] • Peripheral Neuropathy [see Warnings and Precautions (5.3) ] • Central Nervous System Effects [see Warnings and Precautions (5.4) ] • Exacerbation of Myasthenia Gravis [see Warnings and Precautions (5.5) ] • QT Prolongation [see Warnings and Precautions (5.6)] • Other Serious and Sometimes Fatal Adverse Reactions [see Warnings and Precautions (5.7) ] • Hypersensitivity Reactions [see Warnings and Precautions (5.8) ] • Clostridium difficile-Associated Diarrhea [see Warnings and Precautions (5.9) ] • Blood Glucose Disturbances [see Warnings and Precautions (5.11) ] • Photosensitivity/Phototoxicity [see Warnings and Precautions (5.12)] • Development of Drug Resistant Bacteria [see Warnings and Precautions (5.13)] Most common reactions (3% or greate

Frequently Asked Questions

What is Moxifloxacin Hydrochloride Tablets, 400 mg used for?

Moxifloxacin Hydrochloride Tablets, 400 mg contains Moxifloxacin Hydrochloride Tablets, 400 mg. It is a tablet, film coated taken oral. Consult your doctor for specific uses.

Is Moxifloxacin Hydrochloride Tablets, 400 mg a controlled substance?

Moxifloxacin Hydrochloride Tablets, 400 mg is not classified as a controlled substance by the DEA.

What is the generic name for Moxifloxacin Hydrochloride Tablets, 400 mg?

The generic name for Moxifloxacin Hydrochloride Tablets, 400 mg is Moxifloxacin Hydrochloride Tablets, 400 mg. There are no other listed brand versions of Moxifloxacin Hydrochloride Tablets, 400 mg.

What is the NDC code for Moxifloxacin Hydrochloride Tablets, 400 mg 400 mg/1?

The NDC (National Drug Code) for Moxifloxacin Hydrochloride Tablets, 400 mg 400 mg/1 is 70518-4312, listed by REMEDYREPACK INC..

Product NDC

70518-4312

Package NDC

70518-4312-0

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)